An industry consortium supports administration of Salix by regulatory veterinarians only and a ban on adjunct bleeder drugs, but will continue to study a pilot program proposal to ban the use of race-day Salix in 2-year-olds.
Let's put all U.S. racing on par with the rest of the world. read blog
A baby step toward progress was how organizers described the two-day International Race Day Medication Summit held June 13-14 at Belmont Park.
The medication summit will shed plenty of light on how the U.S. can improve its policies. Read Blog
- By Blood-Horse Staff
- International, Northeast Region, Midwest Region, Southeast Region, Southwest Region, West Region, Kentucky
The first international summit on race-day medication as it relates to exercise-induced pulmonary hemorhaging will be June 13-14 at Belmont Park.
The first 'International Summit on Race Day Medication, EIPH and the Racehorse' has been scheduled for June 13-14 in New York City.
As expected the Racing Medication and Testing Consortium board of directors said April 20 it will join the National Thoroughbred Racing Association and American Association of Equine Practitioners in organizing a drug summit.
- By Tom LaMarra
Industry organizations including the National Thoroughbred Racing Association will propose an international summit on equine medication this year in the wake of calls for the race-day ban of anti-bleeding drugs.
The racetrack association supports a realistic and practical approach to a proposal to ban all race-day medication in racehorses within five years.
- By Tom LaMarra
Dr. Scot Waterman, executive director of the Racing Medication and Testing Consortium for almost 10 years, is leaving the post at the end of April, according to multiple industry sources.
- By Tom LaMarra
In an announcement that could meet with disagreement with some horsemen's groups and perhaps others, the Association of Racing Commissioners International has called for a five-year phase-out of equine medication in racing.
As McKinsey & Company prepares for The Jockey Club a broad report on Thoroughbred racing, a horsemen's group has reviewed a medication study the company authored 20 years ago.
Laboratories that test samples for the presence of drugs in California, Delaware, Kentucky, New York, Pennsylvania, West Virginia, and other states have signed letters of intent to submit to accreditation.
Money will go to Dr. Heather DiMaio Knych and Dr. Mary Robinson for post-doctoral research.
U.S. Sen. Tom Udall and U.S. Rep. Ed Whitfield requested detailed answers on the progress of drug testing and monitoring and racetrack safety from industry leaders.
- By Tom LaMarra
The Racing Medication and Testing Consortium has lowered the testing threshold level for phenylbutazone, a commonly used non-steroidal anti-inflammatory drug, but has kept the administration time at 24 hours prior to a race.
The Racing Medication and Testing Consortium is currently seeking applications for the position of director of research.
Moving forward with its initiative to significantly change the structure of drug testing in U.S. horse racing, the Racing Medication and Testing Consortium (RMTC) board of directors has approved the formation of a committee to oversee the implementation of the Drug Testing Initiative (DTI) Task Force recommendations on quality assurance and laboratory accreditation programs for U.S. horse racing drug testing laboratories.
- By Tom LaMarra
The Association of Racing Commissioners International is looking at extending the cutoff time for use of non-steroidal anti-inflammatory drugs in racehorses beyond 24 hours prior to a race, but horsemen's groups claim the action is premature.
The Racing Medication and Testing Consortium board of directors has approved new national laboratory standards for testing, the implementation of a laboratory accreditation program and a new independent Equine Quality Assurance Program.
The National Horsemen's Benevolent and Protective Association said July 1 it plans to be more involved as the racing industry considers medication and drug-testing policies horsemen believe could be detrimental and counterproductive.
The Racing Medication and Testing Consortium is developing protocol designed to streamline and improve equine drug-testing in the United States. And it is taking a few pages from a 1991 study that didn't gain any traction in the racing industry when it was released.
Year-and-a-half-old testing for anabolic steroids in racehorses produced some unusual results -- including the discovery of a Standardbred filly that's actually a male.
Though most racing jurisdictions in North America have greatly curtailed the use of race-day medication, two drugs commonly used in racehorses are getting a hard look from industry officials.
The Racing Medication and Testing Consortium board of directors Feb. 6 received an update on an anabolic steroids study, results of which will be used to set thresholds for testing in plasma.
The Jockey Club Thoroughbred Safety Committee said Feb. 11 it will fund a Racing Medication and Testing Consortium frozen-sample and retrospective testing program that will begin in April.
The Racing Medication and Testing Consortium recently prepared a list of 2009-10 goals, one of which is tackling use of corticosteroids in racehorses.
Using emergency regulations, the Louisiana Racing Commission has banned the use of anabolic steroids in racehorses effective Jan. 1, 2009.
The Racing Medication and Testing Consortium is developing a five-prong plan to implement equine drug-testing standards similar to those used by the World Anti-Doping Agency.
The Kentucky Equine Drug Research Council has adopted a recommended ban on anabolic steroids that is classified as the "toughest in the country" by the panel's chairman.
Kentucky racing officials said they intend on having regulations for use of anabolic steroids in racehorses in place as quickly as possible, but discussion and research are still needed.
The New York State Racing and Wagering Board on May 29 passed proposed restrictions on use of anabolic steroids in racehorses for Thoroughbred and Standardbred racing.
If your horse is being treated with anabolic steroids and you plan to race in California, the time to stop administering them is now. That's the word from Richard Shapiro, chairman of the California Horse Racing Board, and Dr. Rick Arthur, the agency's equine medical director.
The Racing Medication and Testing Consortium sponsored an equine racing chemist workshop to foster uniformity in drug testing of the androgenic anabolic steroids from April 27-30 at the University of California at Davis.
The California Horse Racing Board has issued an advisory to explain the changing regulatory scheme of anabolic steroids.
The board of directors of the Racing Medication and Testing Consortium (RMTC), in consultation with the RMTC Scientific Advisory Committee, approved policy recommendations for the use of steroids. The action took place at an RMTC board meeting March 25 Austin, Texas.
- By Dan Liebman
By Dan Liebman - Imagine using something in your profession for 25 years because you believe it to be beneficial, and then having regulators take it away from you.
The Racing Medication and Testing Consortium will hold its spring board of directors meeting March 25 in conjunction with the Association of Racing Commissioners International annual convention in Austin, Texas.
By Alex Waldrop - On Feb. 27, I appeared before a Congressional Subcommittee for a hearing entitled, "Drugs in Sports: Compromising the Health of Athletes and Undermining the Integrity of Competition."
National Thoroughbred Racing Association president and chief executive officer Alex Waldrop has been asked to testify in Washington, D.C., during a hearing titled "Drugs in Sports: Compromising the Health of Athletes and Undermining the Integrity of Competition."
- By Dan Liebman
By Dan Liebman - The industry has one chance to get it right or the federal government may intervene.
Indiana is moving forward with plans to implement regulation and testing of anabolic steroids in racehorses April 1.
A national regulator said uniform implementation of regulations for anabolic steroids in racehorses isn't practical and suggested horsemen "come clean to the races" voluntarily beginning April 1.
Members of the Racing Medication and Testing Consortium haven't backed away from a call for regulation of anabolic steroids in racehorses, but on Jan. 31 they endorsed a Dec. 31, 2008, deadline for nationwide adoption of a model rule.
The head of a major horsemen's group in the United States has proposed a national approach for regulation of anabolic steroids in racehorses with an implementation date of Jan. 1, 2009.
- By Tom LaMarra
- News, Northeast Region, Midwest Region, Southeast Region, Southwest Region, West Region
The National Horsemen's Benevolent and Protective Association is formulating a position on regulation of anabolic steroids in racehorses.
The Kentucky Horse Racing Authority supports the regulation of anabolic steroids in racehorses in the state, and took the first step toward drafting and adopting the revised model rule offered by the Association of Racing Commissioners International and Racing Medication and Testing Consortium during a Dec. 17 meeting.
As expected, states in the Mid-Atlantic region have announced they are working to implement a ban on anabolic steroids in racehorses effective April 1, 2008.
The Racing Medication and Testing Consortium has hired Dr. William Muir as research coordinator and Hallie Roach as communications coordinator.
- By Ron Mitchell
After nearly five years in existence, the Racing Medication and Testing Consortium is refocusing on some of its core goals such as uniform rules, drug research, and standardizing drug-testing procedures in the United States.
Most Popular Stories
- California Chrome Returning Early From Break
- The Pizza Man Key Ingredient To Arlington
- Wise Dan Turns in First Breeze Since Surgery
- Multiple Group I Winner The Fugue Retired
- The Influence of His Majesty
- Jockey Stevens to Undergo Knee Surgery
- Tattersalls July Sale Ends on High Note
- French Derby Duo Clash Again at Longchamp
- Belmont to Offer Low-Roller Player Tourney
- AHC: Bonus Depreciation Bill Passed by House